These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TPA patent battle continues in court. Johnston K Nature; 1987 Jun 18-24; 327(6123):546. PubMed ID: 3110620 [No Abstract] [Full Text] [Related]
3. Cross-examination ends in TPA patent case. Newmark P Nature; 1987 Jun 25-Jul 1; 327(6124):650. PubMed ID: 3110622 [No Abstract] [Full Text] [Related]
4. Problems over TPA patent for Genentech in Japan. Swinbanks D Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683 [No Abstract] [Full Text] [Related]
5. TPA patent battle rages in United Kingdom. Johnston K Nature; 1987 Jun 11-17; 327(6122):450. PubMed ID: 3108671 [No Abstract] [Full Text] [Related]
6. Single amino-acid makes big difference in patent court. Swinbanks D Nature; 1994 Nov; 372(6502):123. PubMed ID: 7969438 [No Abstract] [Full Text] [Related]
12. New battle over TPA. Ezzell C Nature; 1989 Aug; 340(6233):418. PubMed ID: 2502715 [No Abstract] [Full Text] [Related]
13. Cloning and characterization of a cDNA for rat tissue-type plasminogen activator. Ny T; Leonardsson G; Hsueh AJ DNA; 1988 Dec; 7(10):671-7. PubMed ID: 3148445 [TBL] [Abstract][Full Text] [Related]
14. Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli. Harris TJ; Patel T; Marston FA; Little S; Emtage JS; Opdenakker G; Volckaert G; Rombauts W; Billiau A; De Somer P Mol Biol Med; 1986 Jun; 3(3):279-92. PubMed ID: 3090401 [TBL] [Abstract][Full Text] [Related]
15. Inventions in biotechnology and the assessment of obviousness. Finney K Australas Biotechnol; 1994; 4(5):280-3. PubMed ID: 7765674 [TBL] [Abstract][Full Text] [Related]
16. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats? Haelewyn B; Risso JJ; Abraini JH J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551 [TBL] [Abstract][Full Text] [Related]
17. Opinions evolve on Kauffman patent. Dove A Nat Biotechnol; 2000 Apr; 18(4):373. PubMed ID: 10748506 [No Abstract] [Full Text] [Related]
18. The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012). Tomlinson JE; Byrne E; Pusterla N; Magdesian KG; Hilton HG; McGorum B; Davis E; Schoster A; Arroyo L; Dunkel B; Carslake H; Boston RC; Johnson AL J Vet Intern Med; 2015; 29(5):1403-9. PubMed ID: 26256909 [TBL] [Abstract][Full Text] [Related]
19. The end of DNA patents in the United States? Webber P Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004 [TBL] [Abstract][Full Text] [Related]
20. rtPA is a well-characterized protein. O'Connor JV Dev Biol Stand; 1998; 96():113-21. PubMed ID: 9890524 [No Abstract] [Full Text] [Related] [Next] [New Search]